NRXP – nrx pharmaceuticals, inc. (US:NASDAQ)
Stock Stats
News
NRx Pharmaceuticals (NRXP) was upgraded by Zacks Research from "strong sell" to "hold".
NRx Pharmaceuticals (NRXP) had its price target raised by HC Wainwright from $40.00 to $45.00. They now have a "buy" rating on the stock.
NRx Pharmaceuticals (Nasdaq: NRXP) Appoints Prof. Joshua Brown MD, PhD, as Chief Medical Innovation Officer [Yahoo! Finance]
NRx Pharmaceuticals (Nasdaq: NRXP) Appoints Prof. Joshua Brown MD, PhD, as Chief Medical Innovation Officer
NRx Pharmaceuticals (NASDAQ:NRXP) had its "buy" rating reaffirmed by analysts at BTIG Research. They now have a $25.00 price target on the stock.
Form DEFA14A NRX Pharmaceuticals,
Form ARS NRX Pharmaceuticals, For: Dec 31
Form DEF 14A NRX Pharmaceuticals, For: Mar 23
Form 4 NRX Pharmaceuticals, For: Jan 27 Filed by: Casper Joseph Michael
Form 3 NRX Pharmaceuticals, For: Jan 27 Filed by: Casper Joseph Michael
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.